Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection

The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection and immunity Jg. 72; H. 5; S. 2574
Hauptverfasser:	Liu, Xiao-Qing, Dosanjh, Davinder, Varia, Hansa, Ewer, Katie, Cockle, Paul, Pasvol, Geoffrey, Lalvani, Ajit
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.05.2004
Schlagworte:	Adolescent Adult Aged Amino Acid Sequence Antigens, Bacterial - genetics Bacterial Proteins - genetics Bacterial Proteins - immunology BCG Vaccine - immunology Case-Control Studies Cross Reactions Female Genes, Bacterial Humans In Vitro Techniques Interferon-gamma - biosynthesis Male Middle Aged Molecular Sequence Data Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - immunology Prospective Studies Sensitivity and Specificity T-Lymphocytes - immunology Tuberculosis - diagnosis Tuberculosis - immunology Tuberculosis - microbiology
ISSN:	0019-9567
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis and M. bovis that are deleted in M. bovis BCG. Proteins encoded in these regions will form the basis of new specific T-cell-based blood tests that do not cross-react with BCG, but only two, early secretory antigen target 6 and culture filtrate protein 10, have been studied in detail in humans. We investigated four novel gene products, encoded by RD2 (Rv1989c) and RD1 (Rv3873, Rv3878, and Rv3879c), that are absent from most or all of the vaccine strains of BCG, respectively. Sixty-seven overlapping peptides were tested in ex vivo gamma interferon enzyme-linked immunospot assays in 49 patients with culture-confirmed tuberculosis and 38 healthy BCG-vaccinated donors. Forty-five percent (95% confidence interval [CI], 31 to 57%) and 53% (95% CI, 39 to 67%) of the tuberculosis patients responded to Rv3879c and Rv3873, respectively, identifying these proteins as major M. tuberculosis T-cell antigens in humans, while 35 and 25% of the patients responded to Rv3878 and Rv1989c, respectively. Of the 38 BCG-vaccinated donors, 1 (2.6%) responded to peptides from Rv3878 and Rv3879c, 3 (7.9%) responded to Rv3873, and none responded to Rv1989c. Exclusion of cross-reactive peptides encoded in conserved motifs of Rv3873, a PPE family member, increased its specificity to 97.4%. The high specificity of Rv3879c peptides and nonconserved Rv3873 sequences, together with their moderate sensitivity in tuberculosis patients, identifies these peptides as candidates for inclusion in new T-cell-based tests for M. tuberculosis infection.
AbstractList	The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis and M. bovis that are deleted in M. bovis BCG. Proteins encoded in these regions will form the basis of new specific T-cell-based blood tests that do not cross-react with BCG, but only two, early secretory antigen target 6 and culture filtrate protein 10, have been studied in detail in humans. We investigated four novel gene products, encoded by RD2 (Rv1989c) and RD1 (Rv3873, Rv3878, and Rv3879c), that are absent from most or all of the vaccine strains of BCG, respectively. Sixty-seven overlapping peptides were tested in ex vivo gamma interferon enzyme-linked immunospot assays in 49 patients with culture-confirmed tuberculosis and 38 healthy BCG-vaccinated donors. Forty-five percent (95% confidence interval [CI], 31 to 57%) and 53% (95% CI, 39 to 67%) of the tuberculosis patients responded to Rv3879c and Rv3873, respectively, identifying these proteins as major M. tuberculosis T-cell antigens in humans, while 35 and 25% of the patients responded to Rv3878 and Rv1989c, respectively. Of the 38 BCG-vaccinated donors, 1 (2.6%) responded to peptides from Rv3878 and Rv3879c, 3 (7.9%) responded to Rv3873, and none responded to Rv1989c. Exclusion of cross-reactive peptides encoded in conserved motifs of Rv3873, a PPE family member, increased its specificity to 97.4%. The high specificity of Rv3879c peptides and nonconserved Rv3873 sequences, together with their moderate sensitivity in tuberculosis patients, identifies these peptides as candidates for inclusion in new T-cell-based tests for M. tuberculosis infection. The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis and M. bovis that are deleted in M. bovis BCG. Proteins encoded in these regions will form the basis of new specific T-cell-based blood tests that do not cross-react with BCG, but only two, early secretory antigen target 6 and culture filtrate protein 10, have been studied in detail in humans. We investigated four novel gene products, encoded by RD2 (Rv1989c) and RD1 (Rv3873, Rv3878, and Rv3879c), that are absent from most or all of the vaccine strains of BCG, respectively. Sixty-seven overlapping peptides were tested in ex vivo gamma interferon enzyme-linked immunospot assays in 49 patients with culture-confirmed tuberculosis and 38 healthy BCG-vaccinated donors. Forty-five percent (95% confidence interval [CI], 31 to 57%) and 53% (95% CI, 39 to 67%) of the tuberculosis patients responded to Rv3879c and Rv3873, respectively, identifying these proteins as major M. tuberculosis T-cell antigens in humans, while 35 and 25% of the patients responded to Rv3878 and Rv1989c, respectively. Of the 38 BCG-vaccinated donors, 1 (2.6%) responded to peptides from Rv3878 and Rv3879c, 3 (7.9%) responded to Rv3873, and none responded to Rv1989c. Exclusion of cross-reactive peptides encoded in conserved motifs of Rv3873, a PPE family member, increased its specificity to 97.4%. The high specificity of Rv3879c peptides and nonconserved Rv3873 sequences, together with their moderate sensitivity in tuberculosis patients, identifies these peptides as candidates for inclusion in new T-cell-based tests for M. tuberculosis infection.The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis and M. bovis that are deleted in M. bovis BCG. Proteins encoded in these regions will form the basis of new specific T-cell-based blood tests that do not cross-react with BCG, but only two, early secretory antigen target 6 and culture filtrate protein 10, have been studied in detail in humans. We investigated four novel gene products, encoded by RD2 (Rv1989c) and RD1 (Rv3873, Rv3878, and Rv3879c), that are absent from most or all of the vaccine strains of BCG, respectively. Sixty-seven overlapping peptides were tested in ex vivo gamma interferon enzyme-linked immunospot assays in 49 patients with culture-confirmed tuberculosis and 38 healthy BCG-vaccinated donors. Forty-five percent (95% confidence interval [CI], 31 to 57%) and 53% (95% CI, 39 to 67%) of the tuberculosis patients responded to Rv3879c and Rv3873, respectively, identifying these proteins as major M. tuberculosis T-cell antigens in humans, while 35 and 25% of the patients responded to Rv3878 and Rv1989c, respectively. Of the 38 BCG-vaccinated donors, 1 (2.6%) responded to peptides from Rv3878 and Rv3879c, 3 (7.9%) responded to Rv3873, and none responded to Rv1989c. Exclusion of cross-reactive peptides encoded in conserved motifs of Rv3873, a PPE family member, increased its specificity to 97.4%. The high specificity of Rv3879c peptides and nonconserved Rv3873 sequences, together with their moderate sensitivity in tuberculosis patients, identifies these peptides as candidates for inclusion in new T-cell-based tests for M. tuberculosis infection.
Author	Cockle, Paul Pasvol, Geoffrey Lalvani, Ajit Dosanjh, Davinder Liu, Xiao-Qing Varia, Hansa Ewer, Katie
Author_xml	– sequence: 1 givenname: Xiao-Qing surname: Liu fullname: Liu, Xiao-Qing organization: Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United kingdom – sequence: 2 givenname: Davinder surname: Dosanjh fullname: Dosanjh, Davinder – sequence: 3 givenname: Hansa surname: Varia fullname: Varia, Hansa – sequence: 4 givenname: Katie surname: Ewer fullname: Ewer, Katie – sequence: 5 givenname: Paul surname: Cockle fullname: Cockle, Paul – sequence: 6 givenname: Geoffrey surname: Pasvol fullname: Pasvol, Geoffrey – sequence: 7 givenname: Ajit surname: Lalvani fullname: Lalvani, Ajit
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/15102765$$D View this record in MEDLINE/PubMed
BookMark	eNpVkMtOwzAQRb0oog_4BfCKXYLt2k2yrEqBSkVIqKwjPyYQlNghtiv1X_hYgtouWM2M5ty5oztFI-ssIHRLSUopy-83y02asVSkTGQ8YSKnKSOEj9CEEFokhVhkYzT1_msYOef5JRpTQQnLFmKCftZ72UQZamexq_Au0dA0uAffOevB4-CwdXto8NsDTbC0ZmhYAlY7Awa_HLRTUgfo69jiEBX0OjbO1x5_gAXc9c5EHTyuXI99B7quao0NBNBnx8_YSvtfWtvquL9CF5VsPFyf6gy9P653q-dk-_q0WS23ieaChCRjQBUjSlZKFpUSOeRQAQciJSUFUJIbIwjwQs1hQJlUvFgwRYkCNi-YZDN0d7w7_PsdwYeyrf1fENKCi77MaC5EkfMBvDmBUbVgyq6vW9kfynOe7Bc6Anys
CitedBy_id	crossref_primary_10_1111_j_1440_1843_2012_02218_x crossref_primary_10_1016_j_cimid_2007_07_003 crossref_primary_10_1016_S0761_8425_05_73019_9 crossref_primary_10_1016_S0761_8425_07_91569_7 crossref_primary_10_1007_s00284_015_0786_x crossref_primary_10_4049_jimmunol_175_12_7930 crossref_primary_10_1186_1471_2334_10_273 crossref_primary_10_1586_ers_09_20 crossref_primary_10_1016_j_ad_2012_07_006 crossref_primary_10_1016_j_micinf_2005_03_013 crossref_primary_10_1038_srep45969 crossref_primary_10_1016_S1473_3099_18_30613_3 crossref_primary_10_1128_CVI_00405_10 crossref_primary_10_1128_CVI_00056_08 crossref_primary_10_1097_01_mcp_0000158726_13159_5e crossref_primary_10_1128_JCM_44_3_1197_1201_2006 crossref_primary_10_1016_j_biologicals_2018_01_006 crossref_primary_10_1016_j_bjid_2018_10_280 crossref_primary_10_1186_1755_8794_1_18 crossref_primary_10_1016_S1773_035X_09_71679_X crossref_primary_10_1128_CVI_00481_12 crossref_primary_10_2217_fmb_11_82 crossref_primary_10_1371_journal_pone_0146905 crossref_primary_10_1111_j_1440_1843_2007_01188_x crossref_primary_10_1128_CVI_05708_11 crossref_primary_10_1016_j_tube_2014_02_002 crossref_primary_10_1128_CVI_13_1_90_97_2006 crossref_primary_10_1292_jvms_15_0216 crossref_primary_10_3390_vaccines9010027 crossref_primary_10_1128_IAI_01436_08 crossref_primary_10_1164_rccm_200508_1294OC crossref_primary_10_1111_j_1574_695X_2010_00677_x crossref_primary_10_1016_j_humimm_2014_02_017 crossref_primary_10_1073_pnas_1015153108 crossref_primary_10_1007_s10096_005_1377_8 crossref_primary_10_1097_QCO_0b013e32813e3fd8 crossref_primary_10_1016_j_mimet_2015_05_007 crossref_primary_10_1016_j_tube_2004_09_003 crossref_primary_10_1016_j_tim_2004_09_007 crossref_primary_10_1128_IAI_73_9_5636_5644_2005 crossref_primary_10_1183_09031936_00148308 crossref_primary_10_1371_journal_pone_0028754 crossref_primary_10_1378_chest_06_2471 crossref_primary_10_1111_j_1440_1843_2009_01692_x crossref_primary_10_7774_cevr_2013_2_2_83 crossref_primary_10_2215_CJN_09231209 crossref_primary_10_1128_CVI_00209_06 crossref_primary_10_1016_S0140_6736_04_17592_2 crossref_primary_10_1371_journal_pone_0027980 crossref_primary_10_1111_1751_7915_12697 crossref_primary_10_1164_rccm_200509_1516PP crossref_primary_10_1016_j_adengl_2012_07_020 crossref_primary_10_1007_s00403_008_0857_y crossref_primary_10_30699_ijmm_17_5_505 crossref_primary_10_3892_mmr_2015_4589 crossref_primary_10_1016_j_rmed_2006_02_032 crossref_primary_10_3389_fimmu_2025_1498448
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1128/IAI.72.5.2574-2581.2004
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Biology
ExternalDocumentID	15102765
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- -DZ -~X .55 .GJ 0R~ 18M 29I 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 85S ABOCM ACGFO ADBBV AENEX AGCDD AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ H~9 IH2 J5H KQ8 L7B MVM NEJ NPM O9- OHT OK1 P2P PKN RHF RHI RNS RPM RSF SJN TR2 TWZ UCJ UPT VH1 VQA W2D W8F WH7 WHG WOQ X7M Y6R YIF ZGI ZXP ~KM 7X8 AAGFI
ID	FETCH-LOGICAL-c450t-72e1b20bafba9fb58e8efe4e0aa109e108dd50e49b3e2e12ab4962b10be2392a2
IEDL.DBID	7X8
ISICitedReferencesCount	70
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000221120100015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0019-9567
IngestDate	Fri Sep 05 11:41:05 EDT 2025 Wed Feb 19 02:33:40 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c450t-72e1b20bafba9fb58e8efe4e0aa109e108dd50e49b3e2e12ab4962b10be2392a2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	15102765
PQID	71855984
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_71855984 pubmed_primary_15102765
PublicationCentury	2000
PublicationDate	2004-05-01
PublicationDateYYYYMMDD	2004-05-01
PublicationDate_xml	– month: 05 year: 2004 text: 2004-05-01 day: 01
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Infection and immunity
PublicationTitleAlternate	Infect Immun
PublicationYear	2004
SSID	ssj0014448
Score	2.050265
Snippet	The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG,...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	2574
SubjectTerms	Adolescent Adult Aged Amino Acid Sequence Antigens, Bacterial - genetics Bacterial Proteins - genetics Bacterial Proteins - immunology BCG Vaccine - immunology Case-Control Studies Cross Reactions Female Genes, Bacterial Humans In Vitro Techniques Interferon-gamma - biosynthesis Male Middle Aged Molecular Sequence Data Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - immunology Prospective Studies Sensitivity and Specificity T-Lymphocytes - immunology Tuberculosis - diagnosis Tuberculosis - immunology Tuberculosis - microbiology
Title	Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection
URI	https://www.ncbi.nlm.nih.gov/pubmed/15102765 https://www.proquest.com/docview/71855984
Volume	72
WOSCitedRecordID	wos000221120100015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKC6iXFkqBPgAfuHqbeMdJLCGhiraiEruqUEF7W_kxliqVZNlkK_W_9Md2nAeIA-qhlyiHWInsyTffeD7PMPYRA_ncuGujchwLyAondE5RK0IK0rugTZsu-Pktn06L2UxfrLFPw1mYKKscMLEFal-5uEd-RBgaa4nD58VvEXtGxdxq30DjCdsYE5GJNp3P_uYQAKDHYS0oCsh7dRcB8tH58fkolyM1IoMFIVXRRYr_Z5mttznbftx3vmBbPcvkx51ZvGRrWO6wZ13fydsd9nzSZ9RfsbvTP-W-eRX4pYg7-XzZKWex5k3Fy-oGr_n3k1RwU3q6kSJWv_To-eTWER609Z5Xv3izsrh0q-uqvqo5GSbyRVdPtuZEjXk81BmFSdxj0wrA2je2TQL_HToIxMpd9uPs9PLLV9F3bBAOVNKIXGJqZWJNsEYHqwosMCBgYkyaaEyTwnuVIGg7RnpUGgs6kzZNLEoiaka-ZutlVeJbxj0YCEDsSFsHIctN5pQyYMeK_C5q3GMfhvmf0x8RJ8eUWK3q-bACe-xNt4TzRVe4Y07shqLwTO0_OPaAbXYSnahsPGQbgbAA37Gn7qa5qpfvW0Oj6_Ricg8Z3t8M
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+T-cell+responses+to+novel+RD1-+and+RD2-encoded+Mycobacterium+tuberculosis+gene+products+for+specific+detection+of+human+tuberculosis+infection&rft.jtitle=Infection+and+immunity&rft.au=Liu%2C+Xiao-Qing&rft.au=Dosanjh%2C+Davinder&rft.au=Varia%2C+Hansa&rft.au=Ewer%2C+Katie&rft.date=2004-05-01&rft.issn=0019-9567&rft.volume=72&rft.issue=5&rft.spage=2574&rft_id=info:doi/10.1128%2FIAI.72.5.2574-2581.2004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon